Jove
Visualize
联系我们

相关概念视频

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

172
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
172
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

222
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
222
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

446
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
446
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

161
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
145

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Military-civilian partnerships in the South Puget Sound: Relationships for healthcare readiness and emergency preparedness.

American journal of surgery·2026
Same author

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same author

Investigating optimal warming techniques for hypothermia in a swine model of ischemia.

American journal of surgery·2026
Same author

The SAGES MASTERS Program: top 10 papers on intracorporeal anastomosis in right colectomy.

Surgical endoscopy·2025
Same author

A pilot study on the impact of da Vinci 5's force feedback on clinical outcomes: Does it lead to less tissue trauma in colorectal surgery?

American journal of surgery·2025
Same author

Breaking point: Musculoskeletal combat injuries in Iraq, Afghanistan, and Syria-Epidemiology and future directions of care on the battlefield after over two decades of war.

The journal of trauma and acute care surgery·2025
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 27, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.1K

克洛斯特里迪奥伊德困难结肠炎

Luke Pumiglia1, Lexi Wilson2, Laila Rashidi3

  • 1Department of General Surgery, Madigan Army Medical Center, 9040 Jackson Avenue, Joint Base Lewis-McChord, WA 98431, USA.

The Surgical clinics of North America
|April 27, 2024
PubMed
概括
此摘要是机器生成的。

难治性结肠炎,通常是医院获得的腹,用fidaxomicin治疗. 复发病例和高风险人群可能会从fidaxomicin或bezlotoxumab中受益,强调抗生素管理.

关键词:
克洛斯特里迪奥伊德困难结肠炎菲达克索米奇因 (Fidaxomicin) 是一种药物.发性大肠炎的发生.在医院获得的腹.毒素是一种毒素.

更多相关视频

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

38.8K

相关实验视频

Last Updated: Jun 27, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.1K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

38.8K

科学领域:

  • 传染性疾病 传染性疾病
  • 胃肠病学 胃肠病学
  • 微生物学 微生物学

背景情况:

  • 硬直肠炎是医院获得的腹的一个重要原因.
  • 它经常与先前的抗生素使用有关.
  • 症状范围从水性腹到严重的症状,如震惊或巨结肠在突发病例.

研究的目的:

  • 概述Clostridioides困难结肠炎的治疗策略.
  • 突出非 fulminant 和 fulminant 疾病表现的管理.
  • 强调包括抗生素管理在内的预防措施.

主要方法:

  • 审查目前的临床指导方针和Clostridioides困难结肠炎的治疗选择.
  • 讨论药理疗法,包括菲达克索米辛和贝兹洛托克苏马布.
  • 强调抗生素管理在预防中的作用.

主要成果:

  • 非流行的Clostridioides难治性大肠炎主要用口服的fidaxomicin治疗.
  • 复发的C. difficile大肠炎也需要费达克索米辛治疗.
  • 贝兹洛托克苏马布是容易复发的高风险人群的选择.
  • Fulminant 疾病需要积极的医疗管理和外科咨询.

结论:

  • 菲达克索米辛是初始和复发性艰难结肠炎的关键治疗方法.
  • 贝兹洛托克苏马布为特定患者群体提供了额外的治疗选择.
  • 预防C. difficile结肠炎取决于有效的抗生素管理计划.